Neutralizing the Virus: A Focus on SARS-CoV-2–Specific Monoclonal Antibodies

Educational Impact Challenge The goal of this activity is to increase clinicians’ knowledge and understanding of how neutralizing monoclonal antibodies function to both treat patients with COVID-19 and prevent disease in others.  Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after […]

Read More

COVID-19: Monoclonal Antibody / Anxiety & Depression / Helmet Ventilation vs. High-Flow Nasal Oxygen / Bamlanivimab & Variants

Monoclonal antibody treatment: GlaxoSmithKline and Vir Biotechnology are seeking emergency use authorization for their investigational monoclonal antibody treatment for early COVID-19. In an interim analysis of an efficacy trial of nearly 600 adults with COVID-19 who were at high risk for hospitalization, VIR-7831 was associated with an 85% lower risk […]

Read More